🔎 Trials Near Me

ホーム › ループス › フロリダ州

フロリダ州におけるループスの臨床試験

フロリダ州内の拠点で、ループスに関する23件の研究が参加者を募集しています。

フロリダ州内の都市

公式研究テキスト(英語)

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

  • Clinical Res Of W Florida, Clearwater
  • GNP Research, Cooper City
  • Homestead Assoc In Research Inc, Homestead
  • 他2件
被験者募集中第3相
12歳〜100歳 · 全性別 · 2026/10/01更新 · NCT06133972

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

  • Royal Research Corp, Hollywood
  • Florida Kidney Physicians, Riverview
  • Florida Kidney Physicians, Riverview
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/10/01更新 · NCT05268289

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

  • AARDS Research, Inc., Aventura
  • Meris Clinical Research-Brandon-69466, Brandon
  • Clinical Research of West Florida, Inc., Clearwater
  • 他2件
被験者募集中第2相
18歳〜74歳 · 全性別 · 2026/10/01更新 · NCT07409181

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

  • Research Site, Brandon
  • Research Site, Miami
  • Research Site, Miami
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/25更新 · NCT07430306

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  • Arthritis & Rheumatic Disease Specialties, Aventura
  • Clinical Research of West Florida 1, Clearwater
  • Avanti Clinical Research Corp, Hialeah
  • 他5件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07438496

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

  • Clinical Research Of West Florida - Phase I Unit /ID# 279292, Clearwater
  • Finlay Medical Research - Greenacres /ID# 278380, Greenacres City
  • Clinical Research of Osceola /ID# 278374, Kissimmee
  • 他3件
被験者募集中第1相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07607964

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

  • Research Site, Plantation
被験者募集中第1相
18歳〜65歳 · 全性別 · 2026/09/18更新 · NCT07201558

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

  • Omega Research Debary, LLC, DeBary
  • South Florida Rheumatology, Hollywood
  • GTL Medical And Research Group, Miami
  • 他2件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/14更新 · NCT07355218

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

  • GNP Research, Cooper City
  • University of Florida Clinical Research Center, Gainesville
  • Miami Dermatology and Laser Research, Miami
  • 他1件
被験者募集中第2相
12歳〜70歳 · 全性別 · 2026/09/14更新 · NCT07570862

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

  • GNP Research at Mark Jaffe, MD, Cooper City
  • Advance Medical Research Center, Miami
  • Diverse Clinical Research LLC, Miami
  • 他2件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/11更新 · NCT07332481

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Mayo Clinic, Jacksonville
被験者募集中第1相
18歳〜74歳 · 全性別 · 2026/09/10更新 · NCT07085104

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

  • Sl0044 50239, Brandon
  • Sl0044 50630, Clearwater
  • Sl0044 50751, Coral Gables
  • 他9件
被験者募集中第3相
16歳以上 · 全性別 · 2026/09/04更新 · NCT06617325

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

  • Centre for Rheumatology, Immunology and Arthritis, Fort Lauderdale
  • South Florida Rheumatology, Hollywood
  • LIFE Clinical Trials, Margate
  • 他1件
被験者募集中観察研究
16歳以上 · 全性別 · 2026/09/03更新 · NCT07175285

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • Mayo Clinic, Jacksonville
被験者募集中第1/2相
18歳〜65歳 · 全性別 · 2026/08/26更新 · NCT06121297

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  • Bioresearch Partner Coral Terrace, South Miami
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/08/21更新 · NCT06570798

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

  • Highlands Advanced Rheumatology And Arthritis Center - Avon Park /ID# 278239, Avon Park
  • Clinical Research Of West Florida - Phase I Unit /ID# 275834, Clearwater
  • Life Clinical Trials - Colonial Drive - Margate /ID# 276050, Margate
  • 他1件
被験者募集中第1相
18歳〜75歳 · 全性別 · 2026/08/10更新 · NCT06977724

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

  • Dolphin Medical Research, Doral
  • Alloy Clinical Research LLC, Kissimmee
  • SouthCoast Research Center, Miami
  • 他4件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/07/30更新 · NCT07201129

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

  • Omega Research Group, Orlando
被験者募集中第1相
18歳〜70歳 · 全性別 · 2026/06/05更新 · NCT06613360

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

  • US03-0, Clearwater
  • US05-0, Orlando
被験者募集中第1/2相健康なボランティア歓迎
18歳〜70歳 · 全性別 · 2026/06/02更新 · NCT06625671

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • University of Florida, Gainesville
  • Nicklaus Children's Hospital, Miami
被験者募集中第1相
12歳〜70歳 · 全性別 · 2026/05/22更新 · NCT06308978

Lupus Landmark Study: A Prospective Registry and Biorepository

  • University of Miami, Miami
被験者募集中観察研究
18歳〜110歳 · 全性別 · 2026/04/15更新 · NCT05934149

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

  • IRIS Research and Development, LLC, Plantation
被験者募集中第1相
18歳以上 · 全性別 · 2024/09/03更新 · NCT06581562

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。